Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARQT compared with PVLA: revenue, margins and what each company keeps, and the suppliers and customers both name
ARQT
Arcutis Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PVLA
Palvella Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARQT
Arcutis Biotherapeutics, Inc.
vs
PVLA
Palvella Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ARQT
Arcutis Biotherapeutics, Inc.
Change
32.03
· pre 31.06
Mkt cap
$4.0B
Revenue
$130M
Q2 FY26
Revenue
$376M
FY25
PVLA
Palvella Therapeutics, Inc.
Change
145.55
· pre 145.98
· delayed
Pre-market
Sep 2 '83
Mkt cap
—
Revenue
—
Revenue
—
vs
Compare
Pre-market
Sep 2 '83
ARQT
Arcutis Biotherapeutics, Inc.
vs
PVLA
Palvella Therapeutics, Inc.
32.03
pre 31.06
Price
145.55
pre 145.98
delayed
$4.0B
Mkt cap
—
Q2 FY26
$130M
Revenue
—
FY25
$376M
Revenue
—
Change
Change
ARQT
32.03
vs
PVLA
145.55
Pre-market
Sep 2 '83
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
PVLA: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ARQT
5
AZN
AstraZeneca AB
supplier
—
Jiangsu Hengrui Medicine
unlisted
supplier
—
Hangzhou Zhongmei Huadong Pharmaceutical
unlisted
customer
—
Kowa Pharmaceuticals America
unlisted
customer
1 more · ARQT chain
›
Shared
0
No disclosed counterparties: PVLA.
Only PVLA
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ARQT, solid
PVLA, dashed